The Samsung LABGEOIB Troponin I Test is for the quantitative determination of Troponin I (cTnI) in lithium heparin human whole blood and plasma. cTnI determinations aid in the diagnosis of myocardial infarction (MI) and patients with non-ST-segment elevation (NSTEMI) acute coronary syndromes (ACS).
The Samsung LABGEOIB CHF Test is for the quantitative determination of N-terminal probrain natriuretic peptide (NT-proBNP) in EDTA and lithium heparin human whole blood and plasma. NT-proBNP determinations aid in the diagnosis and management of Congestive Heart Failure (CHF).
The Samsung LABGEOIB CHF Plus Test is for the quantitative determination of Troponin I (cTnI) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in lithium heparin human whole blood and plasma.
Samsung LABGEOIB Cardiac 3-in-1 Panel Test is for the quantitative determination of Troponin I (cTnI), Creatine Kinase isoform MB (CK-MB), Myoglobin in lithium heparin human whole blood and plasma.
The Samsung LABGEOIB D-Dimer Test is for the quantitative determination of D-Dimer in lithium heparin and citrated human whole blood and plasma. D-Dimer determinations aid in the quantitative assessment and evaluation of patients presenting with clinical symptoms of Venous Thromboembolism (VTE) including severely evolving disseminated intravascular coagulation (DIC), pulmonary embolism (PE) and deep vein thrombosis (DVT).
The Samsung LABGEOIB SOB Cardiac 3 Panel Test is for the quantitative determination of Troponin I (cTnI), NT-proBNP and D-Dimer in lithium heparin human whole blood and plasma. The SOB (Shortness of Breath) test panel is intended as an aid in the differential diagnosis and prognostic assessment of patients with symptoms of chest pain, typically accompanied by respiratory distress.
The Samsung LABGEOIB beta-hCG Test is for the quantitative determination of human chorionic gonadotropin in lithium heparin human blood and plasma.
The Samsung LABGEOIB TSH Test is for the quantitative determination of Thyorid-stimulating hormone in lithium heparin human whole blood and plasma.
The Samsung IB B·R·A·H·M·S PCT is for the quantitative determination of Procalcitonin in EDTA whole blood or plasma to aid in the early detection and differential diagnosis of clinically relevant bacterial infections to assess the degree of severity and to prognosticate the outcome of systemic bacterial infection, sepsis, severe sepsis, and septic shock. Also, this test aids in the monitoring of antibiotic treatment within the measuring range and in the assessment of successful antibiotic treatment within the measuring range.
* Please refer to the insert of each test menu for the complete intended use statement